Challenges for IL-15 immunotherapy, however, include the inhibitory actions of immunological checkpoints that it induces, and thus there is a considerable emphasis on identifying new mechanisms of action that improve the functionality of IL-15 therapy in cancer patients (13). This evidence concerns the gene IL15 and cancer.